Enhancing Proteomics through Collaboration
SCIEX and Bioinformatics Solutions Inc. (BSI) have embarked on a notable collaboration to enhance proteomic technology in the healthcare field. This partnership focuses on the co-development of the new software PEAKS 12.5, designed to optimize the capabilities of the ZenoTOF 7600+ system. SCIEX is a well-known leader in life science analytical technologies, while BSI specializes in cutting-edge deep learning solutions for proteomics.
Introduction to PEAKS 12.5
The recently launched PEAKS 12.5 software represents a significant advancement in data processing and analysis for proteomics research. This innovative software integrates deep learning algorithms with a unique de novo assisted pipeline, enabling users to extract high-quality data from the instrument’s scanning Q1 quadrupole dimension effectively. The new scoring algorithm combines Data-Dependent Acquisition (DDA) and Data-Independent Acquisition (DIA) methods, significantly improving sensitivity and accuracy in both identification and quantification.
The Operational Benefits
With PEAKS 12.5, researchers can visualize the Q1 profile of each identified peptide through an interactive graphical user interface (GUI). The ability to see these profiles allows scientists to interpret the results easily, validate their findings, and gain insights into complex data involving native and modified peptides. Moreover, this software enables the differentiation of co-eluting fragment ions, which can often complicate data analysis.
Insights from the Experts
Discussing the potential impact of this software, Baozhen Shan, the CEO and Chief Scientific Officer at BSI, highlighted the importance of visualization in proteomics, especially as research flows into clinical applications. By providing researchers access to data that represents quality metrics like peak shape and curvature, PEAKS 12.5 enhances accuracy and aids in distinguishing isomers. This feature is crucial as proteomic data increasingly influences medical diagnostics and therapeutic developments.
Joint Vision for the Future
The anticipation surrounding this collaboration reflects a shared goal between SCIEX and BSI: to empower the proteomics community with reliable data that can lead to meaningful biological insights. Jose Castro-Perez, Vice President of Product Management at SCIEX, expressed his excitement about this progress, emphasizing the plans to utilize multidimensional data derived from the ZenoTOF 7600+ system to enhance precision medicine research.
Commercial Reseller Announcement
This latest development not only illustrates the growing partnership between SCIEX and BSI but also marks SCIEX's new role as an official commercial reseller of the PEAKS Studio platform. This arrangement positions both companies to expand their reach and offer innovative solutions to research and clinical labs globally.
About SCIEX
SCIEX has built a legacy over the past 50 years, providing advanced analytical solutions for the most pressing challenges in quantifying and characterizing complex biological samples. The company is recognized for developing groundbreaking technologies, including the first successful triple quadrupole mass spectrometer, which paved the way for modern analytic practices. They continue to innovate relentlessly, helping researchers across various life sciences disciplines achieve accurate and reliable results.
Committed to advancing human wellness through precise scientific solutions, SCIEX supports its customers with exceptional reliability and service. This commitment strengthens their position as a trusted partner in research and healthcare.
Connect with SCIEX
As a proud member of the Danaher Corporation, SCIEX benefits from a vast network of expertise and resources, enhancing their capability to provide transformative scientific solutions. They are dedicated to improving lives with cutting-edge technology, offering comprehensive support across biotechnology, diagnostics, and life sciences.
For more information about SCIEX’s offerings and to stay updated on the latest in mass spectrometry and proteomics, interested parties are encouraged to visit their official website.
Frequently Asked Questions
What is the significance of PEAKS 12.5?
PEAKS 12.5 enhances data sensitivity and accuracy, allowing researchers to visualize complex proteomics data effectively.
How does SCIEX support researchers?
SCIEX provides advanced analytical solutions and ongoing support, helping researchers achieve reliable results in their studies.
What role does BSI play in this collaboration?
BSI brings expertise in deep learning and proteomics technology, partnering with SCIEX to advance innovative solutions.
Why is visualization important in proteomics?
Visualization aids researchers in interpreting data quality, crucial for accurate analyses in clinical and research applications.
How has SCIEX impacted the field of life sciences?
SCIEX has influenced numerous breakthroughs in life sciences through its innovative analytical technologies for over five decades.
